These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 31402166)

  • 21. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
    Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
    J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer.
    Van Trappen P
    Surg Oncol; 2022 May; 41():101745. PubMed ID: 35358912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
    Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.
    Ianieri MM; Puppo A; Novelli A; Campolo F; Staniscia T; Di Martino G; Piovano E; Bruni F; Roviglione G; Mautone D; Ceccaroni M
    Gynecol Obstet Invest; 2019; 84(4):383-389. PubMed ID: 30661071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
    Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
    J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes.
    Huber D; Hurni Y
    J Minim Invasive Gynecol; 2024 May; 31(5):438-444. PubMed ID: 38428574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic Typical and Atypical Locations of Sentinel Node Mapping with Indocyanine Green: Comparison of 2 Near-Infrared Fluorescence Systems.
    Di Martino G; Reato C; Verri D; Dell'Orto F; Buda A
    J Minim Invasive Gynecol; 2018; 25(3):384-385. PubMed ID: 28939481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.
    Tanner EJ; Sinno AK; Stone RL; Levinson KL; Long KC; Fader AN
    Gynecol Oncol; 2015 Sep; 138(3):542-7. PubMed ID: 26095896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer.
    Demirayak G; Comba C; Özdemir İA
    J Minim Invasive Gynecol; 2018; 25(5):776. PubMed ID: 29146390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Learning curve for sentinel lymph node mapping in gynecologic malignancies.
    Kim S; Ryu KJ; Min KJ; Lee S; Jung US; Hong JH; Song JY; Lee JK; Lee NW
    J Surg Oncol; 2020 Mar; 121(4):599-604. PubMed ID: 31994195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.